Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05461209
Title A Study of Comparing Talquetamab to Belantamab Mafodotin in Participants With Relapsed/Refractory Multiple Myeloma (MonumenTAL-5)
Acronym MonumenTAL-5
Recruitment Withdrawn
Gender both
Phase Phase III
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Age Groups: senior | child | adult
Covered Countries USA

No variant requirements are available.